# The Hybrid Combination of CCTA and SPECT and CAG for Evaluation Prognosis of CAD: an Observational Follow-up Study

> **NCT04554134** · — · COMPLETED · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 550 (actual)

## Conditions studied

- Coronary Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04554134
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01-01
- **Primary completion:** 2015-01-01
- **Final completion:** 2020-02-01
- **Target enrollment:** 550 (ACTUAL)
- **Last updated:** 2020-09-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04554134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04554134, "The Hybrid Combination of CCTA and SPECT and CAG for Evaluation Prognosis of CAD: an Observational Follow-up Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04554134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*